208 related articles for article (PubMed ID: 10024532)
1. Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.
Leibiger H; Wüstner D; Stigler RD; Marx U
Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):529-38. PubMed ID: 10024532
[TBL] [Abstract][Full Text] [Related]
2. Site-specific N-glycosylation of chicken serum IgG.
Suzuki N; Lee YC
Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
[TBL] [Abstract][Full Text] [Related]
3. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region.
Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M
Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of the oligosaccharides of a human monoclonal anti-lipopolysaccharide immunoglobulin M.
Leibiger H; Kersten B; Albersheim P; Darvill A
Glycobiology; 1998 May; 8(5):497-507. PubMed ID: 9597548
[TBL] [Abstract][Full Text] [Related]
5. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
[TBL] [Abstract][Full Text] [Related]
6. Structure of the murine unglycosylated IgG1 Fc fragment.
Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
[TBL] [Abstract][Full Text] [Related]
7. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
8. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
Kemminer SE; Conradt HS; Nimtz M; Sagi D; Peter-Katalinić J; Diekmann O; Drmić I; Müthing J
Biotechnol Prog; 2001; 17(5):809-21. PubMed ID: 11587568
[TBL] [Abstract][Full Text] [Related]
9. Structure of human transferrin receptor oligosaccharides: conservation of site-specific processing.
Hayes GR; Williams AM; Lucas JJ; Enns CA
Biochemistry; 1997 Apr; 36(17):5276-84. PubMed ID: 9136890
[TBL] [Abstract][Full Text] [Related]
10. The variable domain glycosylation in a monoclonal antibody specific to GnRH modulates antigen binding.
Khurana S; Raghunathan V; Salunke DM
Biochem Biophys Res Commun; 1997 May; 234(2):465-9. PubMed ID: 9177294
[TBL] [Abstract][Full Text] [Related]
11. Impact of variable domain glycosylation on antibody clearance: an LC/MS characterization.
Huang L; Biolsi S; Bales KR; Kuchibhotla U
Anal Biochem; 2006 Feb; 349(2):197-207. PubMed ID: 16360109
[TBL] [Abstract][Full Text] [Related]
12. Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragments.
Leung S; Losman MJ; Govindan SV; Griffiths GL; Goldenberg DM; Hansen HJ
J Immunol; 1995 Jun; 154(11):5919-26. PubMed ID: 7751635
[TBL] [Abstract][Full Text] [Related]
13. Glycobiology: 'the function of sugar in the IgG molecule'.
Dwek RA; Lellouch AC; Wormald MR
J Anat; 1995 Oct; 187 ( Pt 2)(Pt 2):279-92. PubMed ID: 7591992
[TBL] [Abstract][Full Text] [Related]
14. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
[TBL] [Abstract][Full Text] [Related]
15. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
Boehm MK; Woof JM; Kerr MA; Perkins SJ
J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
[TBL] [Abstract][Full Text] [Related]
16. Ammonium ion and glucosamine dependent increases of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells.
Gawlitzek M; Valley U; Wagner R
Biotechnol Bioeng; 1998 Mar; 57(5):518-28. PubMed ID: 10099230
[TBL] [Abstract][Full Text] [Related]
17. A bovine IgG heavy chain contains N-acetylgalactosaminylated N-linked sugar chains.
Aoki N; Furukawa K; Iwatsuki K; Noda A; Sato T; Nakamura R; Matsuda T
Biochem Biophys Res Commun; 1995 May; 210(2):275-80. PubMed ID: 7755601
[TBL] [Abstract][Full Text] [Related]
18. In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase.
Warnock D; Bai X; Autote K; Gonzales J; Kinealy K; Yan B; Qian J; Stevenson T; Zopf D; Bayer RJ
Biotechnol Bioeng; 2005 Dec; 92(7):831-42. PubMed ID: 16187338
[TBL] [Abstract][Full Text] [Related]
19. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
[TBL] [Abstract][Full Text] [Related]
20. Relationship between N-linked oligosaccharide chains of human serum immunoglobulin G and serum tumor markers with non-small cell lung cancer progression.
Kanoh Y; Ohara T; Mashiko T; Abe T; Masuda N; Akahoshi T
Anticancer Res; 2006; 26(6B):4293-7. PubMed ID: 17201147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
